Prenetics Global Limited Class A Ordinary Share (PRE) Dividend History

Prenetics Global Limited is a leading healthtech company specializing in genetic testing, diagnostic services, and digital health solutions. Founded to advance personalized healthcare, the company offers a wide range of genetic and diagnostic testing services, including health and wellness insights, disease risk assessments, and COVID-19 testing. Through its innovative platform, Prenetics aims to empower individuals and healthcare providers with data-driven health information.

Website: https://www.prenetics.com

Dividend History

Pay Date	Amount	Ex Dividend Date	Record Date
March 01, 2016	$0.70	02/17/2016	02/19/2016
December 01, 2015	$0.70	11/04/2015	11/06/2015
September 01, 2015	$0.70	08/05/2015	08/07/2015
June 01, 2015	$0.70	05/06/2015	05/08/2015
February 27, 2015	$0.70	02/11/2015	02/13/2015
December 01, 2014	$0.67	11/18/2014	11/20/2014
August 29, 2014	$0.67	08/14/2014	08/18/2014
May 30, 2014	$0.67	05/15/2014	05/19/2014
February 28, 2014	$0.67	02/13/2014	02/18/2014
November 29, 2013	$0.64	11/14/2013	11/18/2013
August 30, 2013	$0.64	08/15/2013	08/19/2013
May 31, 2013	$0.64	05/16/2013	05/20/2013
March 01, 2013	$0.64	02/14/2013	02/19/2013
November 30, 2012	$0.62	11/15/2012	11/19/2012
August 31, 2012	$0.62	08/16/2012	08/20/2012
June 01, 2012	$0.62	05/17/2012	05/21/2012
March 01, 2012	$0.62	02/15/2012	02/17/2012
December 01, 2011	$0.60	11/16/2011	11/18/2011
September 01, 2011	$0.60	08/17/2011	08/19/2011
June 01, 2011	$0.60	05/18/2011	05/20/2011
March 01, 2011	$0.55	02/16/2011	02/18/2011
December 01, 2010	$0.55	11/17/2010	11/19/2010
September 01, 2010	$0.50	08/18/2010	08/20/2010
June 01, 2010	$0.50	05/19/2010	05/21/2010
March 01, 2010	$0.50	02/17/2010	02/19/2010
December 01, 2009	$0.47	11/18/2009	11/20/2009
September 01, 2009	$0.47	08/19/2009	08/21/2009
June 01, 2009	$0.47	05/20/2009	05/22/2009
March 02, 2009	$0.47	02/18/2009	02/20/2009
December 01, 2008	$0.46	11/19/2008	11/21/2008
August 29, 2008	$0.46	08/19/2008	08/21/2008
June 02, 2008	$0.46	05/21/2008	05/23/2008
March 03, 2008	$0.46	02/20/2008	02/22/2008
December 03, 2007	$0.43	11/20/2007	11/23/2007
August 31, 2007	$0.43	08/17/2007	08/21/2007
June 01, 2007	$0.43	05/18/2007	05/22/2007
March 01, 2007	$0.43	02/14/2007	02/19/2007
December 01, 2006	$0.40	11/17/2006	11/21/2006
September 01, 2006	$0.40	08/18/2006	08/22/2006
June 01, 2006	$0.40	05/18/2006	05/22/2006
March 01, 2006	$0.40	02/15/2006	02/17/2006
December 01, 2005	$0.38	11/17/2005	11/21/2005
September 01, 2005	$0.38	08/18/2005	08/22/2005
June 01, 2005	$0.38	05/18/2005	05/20/2005
March 01, 2005	$0.38	02/16/2005	02/18/2005
December 01, 2004	$0.34	11/17/2004	11/19/2004
September 01, 2004	$0.34	08/18/2004	08/20/2004
June 01, 2004	$0.34	05/19/2004	05/21/2004
March 01, 2004	$0.34	02/18/2004	02/20/2004
December 01, 2003	$0.31	11/19/2003	11/21/2003

Dividends Summary

Prenetics Global Limited Class A Ordinary Share has issued 50 dividend payments over the past 13 years
The most recent dividend was paid 3385 days ago, on March 1, 2016
The first recorded dividend was paid on December 1, 2003
The highest dividend payout was $0.70 per share
The average dividend over this 13 year span is $0.52 per share
Prenetics Global Limited Class A Ordinary Share has increased its dividend payments by 125.81% since 2003

Company News

Nasdaq-Listed Prenetics and David Beckham Officially Launch IM8 Health

David Beckham, a strategic investor in Prenetics, has launched a new health and wellness brand called IM8. IM8 offers two premium products, Daily Ultimate Essentials and Daily Ultimate Longevity, which are now available for purchase globally.

GlobeNewswire Inc.
Prenetics Announces First Quarter 2024 Financial Results

First Quarter Revenue Increased 30.2% and Gross Profit Increased 159.8% from Prior Year Quarter

GlobeNewswire Inc.
Prenetics Announces Fourth Quarter and Full Year 2023 Financial Results

HONG KONG, April 01, 2024 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading genomics-driven health sciences company, today announced unaudited financial results for the fourth quarter and full year ended December 31, 2023, along with recent business updates.

GlobeNewswire Inc.
Prenetics Announces MOU for a Strategic Investment and 5-Year Research Collaboration with Metavisionaries to Pioneer R&D on the International Space Station

(From left: Dr. Ghada Alsaleh, Sonia Pawelczyk, Danny Yeung, Dr. James L. Green, Ahmed Alfandi, Dr. Tara Ruttley, Wasim Ahmed, Dr. Hilde Stenuit, Dr. Camille Alleyne at the MOU signing ceremony in Dubai, UAE Space Agency)

GlobeNewswire Inc.
Prenetics Announces Third Quarter 2023 Financial Results

HONG KONG, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading genomics-driven health sciences company, today announced financial results for the third quarter ended September 30, 2023, along with recent business updates.

GlobeNewswire Inc.

Dividend data last updated 06/07/2025 23:56:01 UTC